Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis

被引:0
|
作者
Andreadou, Elisabeth [1 ]
Kapaki, Elisabeth [1 ]
Kokotis, Panagiotis [1 ]
Paraskevas, George P. [1 ]
Katsaros, Nikolaos [1 ]
Libitaki, Georgia [1 ]
Petropoulou, Olga [1 ]
Zis, Vassilios [1 ]
Sfagos, Constantinos [1 ]
Vassilopoulos, Demetrios [1 ]
机构
[1] Natl Tech Univ Athens, Dept Neurol, Athens, Greece
来源
IN VIVO | 2008年 / 22卷 / 01期
关键词
amyotrophic lateral sclerosis; glutamate; glycine; excitotoxicity; plasma;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Defective glutamate (Glu) metabolism and glutamate excitotoxicity have been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Glycine (Gly), the main inhibitory neurotransmitter, has been shown to potentiate excitatory transmission. In the present study, the levels of Glu and Gly in fasting plasma were measured by high performance liquid chromatography (HPLC) in 20 healthy volunteers and in 65 untreated ALS patients. Increased plasma Glu levels were observed in ALS (p = 0.05), correlating with longer disease duration (p = 0.03, beta=0.34) and male gender (p=0.02). Furthermore, the increase was found only in the spinal subtype of the disease (p = 0.03), while in the bulbar subtype, no significant increase was noted. As regards plasma Gly, no difference was observed between patients and controls; however female patients had higher levels than males. The above results are compatible with the "glutamate hypothesis" of ALS and suggest that the spinal and bulbar-onset subtypes of the disease may be biochemically different.
引用
收藏
页码:137 / 141
页数:5
相关论文
共 50 条
  • [1] Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: The effect of riluzole treatment
    Andreadou, Elisabeth
    Kapaki, Elisabeth
    Kokotis, Panagiotis
    Paraskevas, George P.
    Katsaros, Nikolaos
    Libitaki, Georgia
    Zis, Vassilios
    Sfagos, Constantinos
    Vassilopoulos, Demetrios
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2008, 110 (03) : 222 - 226
  • [2] PLASMA GLUTAMATE LEVELS IN NORMAL SUBJECTS AND IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS
    COTTELL, E
    HUTCHINSON, M
    SIMON, J
    HARRINGTON, MG
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1990, 18 (02) : 283 - 283
  • [3] DIFFERENT PLASMA GLUTAMATE LEVELS IN SUBTYPE OF AMYOTROPHIC-LATERAL-SCLEROSIS
    CAMU, W
    BILLIARD, M
    BALDYMOULINER, M
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1994, 89 (05): : 404 - 405
  • [4] Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis
    Zoccolella, S.
    Simone, I. L.
    Lamberti, P.
    Samarelli, V.
    Tortelli, R.
    Serlenga, L.
    Logroscino, G.
    [J]. NEUROLOGY, 2008, 70 (03) : 222 - 225
  • [5] Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis
    Zoccolella, Stefano
    Simone, Isabella L.
    Lamberti, Paolo
    Specchio, Luigi M.
    Samarelli, Vito
    Tortelli, Rosanna
    D'Errico, Eustachio
    Pelliciari, Roberta
    Messina, Raffaella
    Livrea, Paolo
    Logroscino, Giancarlo
    [J]. NEUROLOGY, 2008, 70 (11) : A195 - A195
  • [6] Amyotrophic lateral sclerosis and glutamate
    Ludolph, AC
    Meyer, T
    Riepe, MW
    Völkel, H
    [J]. RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 1998, 13 (1-2) : 59 - 67
  • [7] INCREASED PLASMA LEAD LEVELS IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS - REPLY
    CONRADI, S
    RONNEVI, LO
    VESTERBERG, O
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1979, 42 (07): : 676 - 676
  • [8] Decreased plasma levels of fibronectin in amyotrophic lateral sclerosis
    Ono, S
    Imai, T
    Shimizu, N
    Nakayama, M
    Mihori, A
    Kaneda, K
    Yamano, T
    Tsumura, M
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2000, 101 (06): : 391 - 394
  • [9] Glutamate, excitotoxicity and amyotrophic lateral sclerosis
    P. J. Shaw
    P. G. Ince
    [J]. Journal of Neurology, 1997, 244 : S3 - S14
  • [10] Glutamate, excitotoxicity and amyotrophic lateral sclerosis
    Shaw, PJ
    Ince, PG
    [J]. JOURNAL OF NEUROLOGY, 1997, 244 (Suppl 2) : S3 - S14